Medicine

Erin Waters

Erin Waters

Shiv Thanigaimani

Shiv Thanigaimani

Alkira Deren

Alkira Deren

Michael Robinson

Michael Robinson

Nalita Turner

Nalita Turner

Bunmi Malau-Aduli

Bunmi Malau-Aduli

Jenna Graffini

Jenna Graffini

Mel Muscat

Mel Muscat

Yvonne Hornby-Turner

Yvonne Hornby-Turner

Geoffrey Dobson

Geoffrey Dobson

Optimisation of Ultra-Small Volume Adenosine, Lidocaine and Mg2+ (ALM) Fluid Resuscitation and 72hr Stabilisation Drip for Uncontrolled Haemorrhage and TBI (Old ID 23011)
Hayley Letson
26 Sep 2016 - 25 Dec 2020
The resuscitation and stabilisation properties of ALM 'one-two treatment' will be investigated in ra...
(COMFITE) Efficacy, acceptability and adherence with custom-made footwear in people with a history of diabetes-related foot disease. (Old ID 26968)
Joseph Moxon
01 Jan 2021 - 12 Dec 2022
Approximately 8% (n=80,000) of Northern Australians have diabetes of whom about a quarter (n=20,000)...
Proposed development of revised framework for operational and implementation research in health and disease control programmes. (Old ID 27222)
Michelle Redman-MacLaren
26 Apr 2021 - 24 Sep 2021
Strong, responsive and resilient health systems are the critical foundation for global health securi...
Proposed development of revised framework for operational and implementation research in health and disease control programmes. (Old ID 27222)
Karen Johnston
26 Apr 2021 - 24 Sep 2021
Strong, responsive and resilient health systems are the critical foundation for global health securi...
Assessment of the efficacy of a novel treatment for Peripheral Artery Disease (PAD) (Old ID 26206)
Joseph Moxon
01 Jul 2018 - 31 Dec 2020
Blockage of leg arteries (peripheral artery disease - PAD) leads to severe exertional leg pain (inte...
Design, implementation, and evaluation of an intervention for a kidney transplant service in northern Queensland (Phase 2)
Andrew Mallett
11 Dec 2025 - 31 Oct 2029
This study will explore the experiences of kidney transplant recipients and health professionals, pe...
Metformin in the management of abdominal aortic aneurysm (MAGIC) (Old ID 25135)
Joseph Moxon
01 Jan 2019 - 31 Dec 2020
MAGIC will be the first trial to assess the value of metformin wiuth significant preliminary data to...
Tele-DFD: Remotely providing effective healthcare for diabetic foot disease (Old ID 27644)
Joseph Moxon
01 Jul 2022 - 30 Sep 2026
Current models of care for diabetes-associated foot disease (DFD) management are not sustainable due...
Women's Action for Mums and Bubs (WOMB): A pragmatic trial of participatory women's groups to improve Indigenous maternal and child health (Old ID 23276)
Karen Carlisle
01 Jan 2018 - 31 Dec 2023
There is strong evidence elsewhere that involving community women in decision-making about strategie...
Testing a novel treatment for diabetes-associated ischemic foot ulceration. (Old ID 24978)
Joseph Moxon
01 Jan 2020 - 31 Dec 2020
5000 Australians with diabetes have a leg amputations each year. This project investigates a novel d...

A modified MTS proliferation assay for suspended cells to avoid the interference by Hydralazine and beta-Mercaptoethanol

Efficacy of Telmisartan to slow growth of small abdominal aortic aneurysms: a randomized clinical trial

Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever

The iron content of healthy diets for one day for breastfed babies and young children

Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children

How does GP training impact rural and remote underserved communities? Exploring community and professional perceptions

Mouse models for abdominal aortic aneurysm

Risk factors and mouse models of abdominal aortic aneurysm rupture

  • 2020
  • MDPI
  • Researchers:Jonathan Golledge

Meta-analyses of randomized controlled trials reporting the effect of home foot temperature monitoring, patient education or offloading footwear on the incidence of diabetes-related foot ulcers

Endotoxin tolerance in abdominal aortic aneurysm macrophages, in vitro: a case-control study

Title: Editorial board Arteriosclerosis, Thrombosis and Vascular Biology
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2012
Title: Editorial board member, Arteriosclerosis, Thrombosis and Vascular Biology
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2012
Title: Member of The Australian and International Stroke Genetics Collaboration
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2009
Title: Member of The Research Committee of the Faculty Medicine, Health and Molecular Sciences
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2009
Title: Member of the Board of Surgical Research of the Royal Australasian College of Surgeons
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2007
Title: Member of the Australian Vascular Biology Society
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2002
Title: Member of the School of Medicine Research Committee, James Cook University
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2002
Title: Member of the European Society of Vascular Surgery
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 1996
Title: Member of the ethics committee, The Mater Hospital, Townsville
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2002
End Date: 01 Jan 2009
Title: Member of the Biological Sciences selection panel for internal grants, James Cook University
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2003
End Date: 01 Jan 2004